| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||||||||
| Exhibit No. | Description | |||||||
| 104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. | |||||||
| PEPSICO, INC. | ||||||||
| Date: February 2, 2026 | By: | /s/ David Flavell | ||||||
| Name: | David Flavell | |||||||
| Title: | Executive Vice President, General Counsel and Corporate Secretary | |||||||

| Fourth Quarter | Full-Year | |||||||
| Net revenue performance | 5.6% | 2.3% | ||||||
| Foreign exchange impact on net revenue | 2% | —% | ||||||
| Earnings per share (EPS) | $1.85 | $6.00 | ||||||
| EPS change | 68% | (14)% | ||||||
| Foreign exchange impact on EPS | 5% | —% | ||||||
| Fourth Quarter | Full-Year | |||||||
| Organic revenue performance | 2.1% | 1.7% | ||||||
| Core EPS | $2.26 | $8.14 | ||||||
| Core constant currency EPS change | 11% | —% | ||||||
| Revenue | Volume(a) | ||||||||||||||||||||||
GAAP Reported % Change | Percentage Point Impact | Organic % Change | % Change | ||||||||||||||||||||
| Foreign Exchange Translation | Acquisitions and Divestitures | Convenient Foods | Beverages | ||||||||||||||||||||
| PepsiCo Foods North America (PFNA) | 1.5 | — | (2) | (1) | (1) | ||||||||||||||||||
| PepsiCo Beverages North America (PBNA) | 4 | — | (2) | 2 | (4) | ||||||||||||||||||
| International Beverages Franchise (IB Franchise) | 3.5 | (2) | — | 2 | 3 | ||||||||||||||||||
| Europe, Middle East and Africa (EMEA) | 12 | (7) | — | 5 | (5) | 1 | |||||||||||||||||
| Latin America Foods (LatAm Foods) | 11 | (6) | — | 5 | (1) | ||||||||||||||||||
| Asia Pacific Foods | 5 | — | (1) | 4 | 4 | ||||||||||||||||||
| Total | 6 | (2) | (1) | 2 | (2) | 1 | |||||||||||||||||
| Operating Profit and EPS | ||||||||||||||
| GAAP Reported % Change | Percentage Point Impact | Core Constant Currency % Change | ||||||||||||
| Items Affecting Comparability | Foreign Exchange Translation | |||||||||||||
| PFNA | (6) | 4 | — | (2) | ||||||||||
| PBNA | n/m | n/m | — | 33 | ||||||||||
| IB Franchise | 116 | (104) | (2) | 9 | ||||||||||
| EMEA | 72 | (35) | (14) | 23 | ||||||||||
| LatAm Foods | 15 | (0.5) | (8) | 6 | ||||||||||
| Asia Pacific Foods | n/m | n/m | n/m | n/m | ||||||||||
| Corporate unallocated expenses | 3 | (5) | — | (2) | ||||||||||
| Total | 58 | (40) | (4) | 13 | ||||||||||
| EPS | 68 | (52) | (5) | 11 | ||||||||||
| Revenue | Volume(a) | ||||||||||||||||||||||
GAAP Reported % Change | Percentage Point Impact | Organic % Change | % Change | ||||||||||||||||||||
| Foreign Exchange Translation | Acquisitions and Divestitures | Convenient Foods | Beverages | ||||||||||||||||||||
| PFNA | — | — | (2) | (2) | (2) | ||||||||||||||||||
| PBNA | 1.5 | — | — | 1 | (3) | ||||||||||||||||||
| IB Franchise | 2 | — | — | 3 | 1.5 | ||||||||||||||||||
| EMEA | 8 | (2.5) | — | 6 | (5) | — | |||||||||||||||||
| LatAm Foods | — | 5 | — | 4.5 | 1 | ||||||||||||||||||
| Asia Pacific Foods | 2 | 1 | (1) | 1.5 | 4 | ||||||||||||||||||
| Total | 2 | — | (1) | 2 | (2) | — | |||||||||||||||||
| Operating Profit and EPS | ||||||||||||||
| GAAP Reported % Change | Percentage Point Impact | Core Constant Currency % Change | ||||||||||||
| Items Affecting Comparability | Foreign Exchange Translation | |||||||||||||
| PFNA | (7) | 0.5 | — | (6) | ||||||||||
| PBNA | (53) | 59 | — | 6 | ||||||||||
| IB Franchise | 21 | (12) | 0.5 | 9 | ||||||||||
| EMEA | 7 | 8 | (5) | 10 | ||||||||||
| LatAm Foods | (2) | 4 | 6 | 8 | ||||||||||
| Asia Pacific Foods | (2) | 21 | 1 | 20 | ||||||||||
| Corporate unallocated expenses | 6 | 1 | — | 7 | ||||||||||
| Total | (11) | 12 | — | 2 | ||||||||||
| EPS | (14) | 13 | — | — | ||||||||||
| Contacts: | Investor Relations | Communications | |||||||||
| investor@pepsico.com | pepsicomediarelations@pepsico.com | ||||||||||
| (Unaudited) | |||||||||||||||||||||||
| Quarter Ended | Year Ended | ||||||||||||||||||||||
| 12/27/2025 | 12/28/2024 | 12/27/2025 | 12/28/2024 | ||||||||||||||||||||
| Net Revenue | $ | 29,343 | $ | 27,784 | $ | 93,925 | $ | 91,854 | |||||||||||||||
| Cost of sales | 13,723 | 13,181 | 43,066 | 41,744 | |||||||||||||||||||
| Gross profit | 15,620 | 14,603 | 50,859 | 50,110 | |||||||||||||||||||
| Selling, general and administrative expenses | 12,063 | 12,344 | 37,368 | 37,190 | |||||||||||||||||||
Impairment of intangible assets (a) | — | 9 | 1,993 | 33 | |||||||||||||||||||
| Operating Profit | 3,557 | 2,250 | 11,498 | 12,887 | |||||||||||||||||||
| Other pension and retiree medical benefits expense | (224) | (177) | (133) | (22) | |||||||||||||||||||
| Net interest expense and other | (333) | (264) | (1,121) | (919) | |||||||||||||||||||
| Income before income taxes | 3,000 | 1,809 | 10,244 | 11,946 | |||||||||||||||||||
| Provision for income taxes | 445 | 275 | 1,949 | 2,320 | |||||||||||||||||||
| Net income | 2,555 | 1,534 | 8,295 | 9,626 | |||||||||||||||||||
| Less: Net income attributable to noncontrolling interests | 15 | 11 | 55 | 48 | |||||||||||||||||||
| Net Income Attributable to PepsiCo | $ | 2,540 | $ | 1,523 | $ | 8,240 | $ | 9,578 | |||||||||||||||
| Diluted | |||||||||||||||||||||||
| Net income attributable to PepsiCo per common share | $ | 1.85 | $ | 1.11 | $ | 6.00 | $ | 6.95 | |||||||||||||||
| Weighted-average common shares outstanding | 1,371 | 1,377 | 1,373 | 1,378 | |||||||||||||||||||
| Year Ended | |||||||||||
| 12/27/2025 | 12/28/2024 | ||||||||||
| Operating Activities | |||||||||||
| Net income | $ | 8,295 | $ | 9,626 | |||||||
| Depreciation and amortization | 3,451 | 3,160 | |||||||||
| Impairment and other charges | 1,946 | 714 | |||||||||
| Product recall-related impact | — | 187 | |||||||||
| Cash payments for product recall-related impact | (6) | (148) | |||||||||
| Operating lease right-of-use asset amortization | 727 | 655 | |||||||||
| Share-based compensation expense | 288 | 362 | |||||||||
| Restructuring and impairment charges | 983 | 727 | |||||||||
| Cash payments for restructuring charges | (796) | (436) | |||||||||
| Acquisition and divestiture-related charges | 453 | 22 | |||||||||
| Cash payments for acquisition and divestiture-related charges | (228) | (18) | |||||||||
| Pension and retiree medical plan expenses | 504 | 414 | |||||||||
| Pension and retiree medical plan contributions | (472) | (348) | |||||||||
| Deferred income taxes and other tax charges and credits | 71 | (42) | |||||||||
| Tax payments related to the Tax Cuts and Jobs Act | (772) | (579) | |||||||||
| Change in assets and liabilities: | |||||||||||
| Accounts and notes receivable | (580) | (138) | |||||||||
| Inventories | (150) | (314) | |||||||||
| Prepaid expenses and other current assets | 195 | 40 | |||||||||
| Accounts payable and other current liabilities | (677) | (943) | |||||||||
| Income taxes payable | (433) | (123) | |||||||||
| Other, net | (712) | (311) | |||||||||
| Net Cash Provided by Operating Activities | 12,087 | 12,507 | |||||||||
| Investing Activities | |||||||||||
| Capital spending | (4,415) | (5,318) | |||||||||
| Sales of property, plant and equipment | 528 | 342 | |||||||||
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (3,391) | (256) | |||||||||
| Divestitures, sales of investments in noncontrolled affiliates and other assets | 39 | 166 | |||||||||
| Short-term investments, by original maturity: | |||||||||||
| More than three months - purchases | (190) | (425) | |||||||||
| More than three months - maturities | 605 | — | |||||||||
| Three months or less, net | 45 | 5 | |||||||||
| Other investing, net | (100) | 14 | |||||||||
| Net Cash Used for Investing Activities | (6,879) | (5,472) | |||||||||
| Year Ended | |||||||||||
| 12/27/2025 | 12/28/2024 | ||||||||||
| Financing Activities | |||||||||||
| Proceeds from issuances of long-term debt | 8,189 | 4,042 | |||||||||
| Payments of long-term debt | (4,082) | (3,886) | |||||||||
| Short-term borrowings, by original maturity: | |||||||||||
| More than three months - proceeds | 6,391 | 5,786 | |||||||||
| More than three months - payments | (7,920) | (5,639) | |||||||||
| Three months or less, net | 1,170 | 392 | |||||||||
| Cash dividends paid | (7,638) | (7,229) | |||||||||
| Share repurchases | (1,000) | (1,000) | |||||||||
| Proceeds from exercises of stock options | 97 | 166 | |||||||||
| Withholding tax payments on restricted stock units and performance stock units converted | (113) | (135) | |||||||||
| Other financing | (73) | (53) | |||||||||
| Net Cash Used for Financing Activities | (4,979) | (7,556) | |||||||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 422 | (687) | |||||||||
| Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | 651 | (1,208) | |||||||||
| Cash and Cash Equivalents and Restricted Cash, Beginning of Year | 8,553 | 9,761 | |||||||||
| Cash and Cash Equivalents and Restricted Cash, End of Year | $ | 9,204 | $ | 8,553 | |||||||
| 12/27/2025 | 12/28/2024 | ||||||||||
| ASSETS | |||||||||||
| Current Assets | |||||||||||
Cash and cash equivalents | $ | 9,159 | $ | 8,505 | |||||||
Short-term investments | 371 | 761 | |||||||||
Accounts and notes receivable, net | 11,506 | 10,333 | |||||||||
| Inventories: | |||||||||||
| Raw materials and packaging | 2,581 | 2,440 | |||||||||
| Work-in-process | 143 | 104 | |||||||||
| Finished goods | 3,121 | 2,762 | |||||||||
| 5,845 | 5,306 | ||||||||||
| Prepaid expenses and other current assets | 1,068 | 921 | |||||||||
Total Current Assets | 27,949 | 25,826 | |||||||||
| Property, Plant and Equipment, net | 29,905 | 28,008 | |||||||||
| Amortizable Intangible Assets, net | 1,219 | 1,102 | |||||||||
| Goodwill | 18,916 | 17,534 | |||||||||
| Other Indefinite-Lived Intangible Assets | 13,847 | 13,699 | |||||||||
| Investments in Noncontrolled Affiliates | 2,038 | 1,985 | |||||||||
| Deferred Income Taxes | 4,541 | 4,362 | |||||||||
| Other Assets | 8,984 | 6,951 | |||||||||
Total Assets | $ | 107,399 | $ | 99,467 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Short-term debt obligations | $ | 6,861 | $ | 7,082 | |||||||
| Accounts payable and other current liabilities | 25,903 | 24,454 | |||||||||
Total Current Liabilities | 32,764 | 31,536 | |||||||||
| Long-Term Debt Obligations | 42,321 | 37,224 | |||||||||
| Deferred Income Taxes | 3,802 | 3,484 | |||||||||
| Other Liabilities | 7,965 | 9,052 | |||||||||
Total Liabilities | 86,852 | 81,296 | |||||||||
| Commitments and contingencies | |||||||||||
| PepsiCo Common Shareholders’ Equity | |||||||||||
Common stock, par value 12/3¢ per share (authorized 3,600 shares; issued, net of repurchased common stock at par value: 1,367 and 1,372 shares, respectively) | 23 | 23 | |||||||||
| Capital in excess of par value | 4,451 | 4,385 | |||||||||
| Retained earnings | 72,788 | 72,266 | |||||||||
| Accumulated other comprehensive loss | (15,024) | (17,612) | |||||||||
Repurchased common stock, in excess of par value (500 and 495 shares, respectively) | (41,832) | (41,021) | |||||||||
Total PepsiCo Common Shareholders’ Equity | 20,406 | 18,041 | |||||||||
| Noncontrolling interests | 141 | 130 | |||||||||
Total Equity | 20,547 | 18,171 | |||||||||
| Total Liabilities and Equity | $ | 107,399 | $ | 99,467 | |||||||
| Quarter Ended 12/27/2025 | |||||||||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Total | |||||||||||||||||||||||||||||||||||
| Reported Net Revenue, GAAP measure | $ | 8,313 | $ | 8,198 | $ | 1,579 | $ | 6,079 | $ | 3,684 | $ | 1,490 | $ | 29,343 | |||||||||||||||||||||||||||
Impact of foreign exchange translation (a) | 2 | 2 | (29) | (383) | (214) | 6 | (616) | ||||||||||||||||||||||||||||||||||
| Impact of acquisitions and structural changes | (183) | (163) | (1) | 3 | — | (18) | (362) | ||||||||||||||||||||||||||||||||||
Organic Revenue, non-GAAP measure (b) | $ | 8,132 | $ | 8,037 | $ | 1,549 | $ | 5,699 | $ | 3,470 | $ | 1,478 | $ | 28,365 | |||||||||||||||||||||||||||
| Prior Year Reported Net Revenue, GAAP measure | $ | 8,191 | $ | 7,909 | $ | 1,524 | $ | 5,430 | $ | 3,314 | $ | 1,416 | $ | 27,784 | |||||||||||||||||||||||||||
| Impact of divestitures | — | (6) | — | — | — | — | (6) | ||||||||||||||||||||||||||||||||||
Prior Year Organic Revenue, non-GAAP measure (b) | $ | 8,191 | $ | 7,903 | $ | 1,524 | $ | 5,430 | $ | 3,314 | $ | 1,416 | $ | 27,778 | |||||||||||||||||||||||||||
| Reported Net Revenue % Change, GAAP measure | 1.5 | 4 | 3.5 | 12 | 11 | 5 | 6 | ||||||||||||||||||||||||||||||||||
| Impact of foreign exchange translation | — | — | (2) | (7) | (6) | — | (2) | ||||||||||||||||||||||||||||||||||
| Impact of acquisitions and divestitures | (2) | (2) | — | — | — | (1) | (1) | ||||||||||||||||||||||||||||||||||
Organic Revenue % Change, non-GAAP measure (c) | (1) | 2 | 2 | 5 | 5 | 4 | 2 | ||||||||||||||||||||||||||||||||||
| Impact on % Change of: | |||||||||||||||||||||||||||||||||||||||||
Organic volume change (d) | (2) | (5) | 1 | (3) | (1) | 5 | (2) | ||||||||||||||||||||||||||||||||||
| Effective net pricing | 1 | 7 | — | 8 | 6 | — | 4.5 | ||||||||||||||||||||||||||||||||||
| Year Ended 12/27/2025 | |||||||||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Total | |||||||||||||||||||||||||||||||||||
| Reported Net Revenue, GAAP measure | $ | 27,528 | $ | 28,197 | $ | 4,997 | $ | 18,025 | $ | 10,549 | $ | 4,629 | $ | 93,925 | |||||||||||||||||||||||||||
Impact of foreign exchange translation (a) | 37 | 36 | 19 | (409) | 491 | 32 | 206 | ||||||||||||||||||||||||||||||||||
| Impact of acquisitions and structural changes | (570) | (116) | (7) | 33 | — | (44) | (704) | ||||||||||||||||||||||||||||||||||
Organic Revenue, non-GAAP measure (b) | $ | 26,995 | $ | 28,117 | $ | 5,009 | $ | 17,649 | $ | 11,040 | $ | 4,617 | $ | 93,427 | |||||||||||||||||||||||||||
| Prior Year Reported Net Revenue, GAAP measure | $ | 27,431 | $ | 27,769 | $ | 4,879 | $ | 16,658 | $ | 10,568 | $ | 4,549 | $ | 91,854 | |||||||||||||||||||||||||||
| Impact of divestitures | — | (6) | — | — | — | — | (6) | ||||||||||||||||||||||||||||||||||
Prior Year Organic Revenue, non-GAAP measure (b) | $ | 27,431 | $ | 27,763 | $ | 4,879 | $ | 16,658 | $ | 10,568 | $ | 4,549 | $ | 91,848 | |||||||||||||||||||||||||||
| Reported Net Revenue % Change, GAAP measure | — | 1.5 | 2 | 8 | — | 2 | 2 | ||||||||||||||||||||||||||||||||||
| Impact of foreign exchange translation | — | — | — | (2.5) | 5 | 1 | — | ||||||||||||||||||||||||||||||||||
| Impact of acquisitions and divestitures | (2) | — | — | — | — | (1) | (1) | ||||||||||||||||||||||||||||||||||
Organic Revenue % Change, non-GAAP measure (c) | (2) | 1 | 3 | 6 | 4.5 | 1.5 | 2 | ||||||||||||||||||||||||||||||||||
| Impact on % Change of: | |||||||||||||||||||||||||||||||||||||||||
Organic volume change (d) | (2) | (3.5) | — | (3) | — | 5 | (2) | ||||||||||||||||||||||||||||||||||
| Effective net pricing | 1 | 5 | 2 | 9 | 4 | (3) | 4 | ||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate Unallocated Expenses | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Reported Cost of Sales, GAAP measure | $ | 3,311 | $ | 3,861 | $ | 512 | $ | 3,524 | $ | 1,576 | $ | 945 | $ | (6) | $ | 13,723 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 6 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (119) | — | — | 4 | (2) | — | — | (117) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (4) | (7) | — | — | — | — | — | (11) | |||||||||||||||||||||||||||||||||||||||||||||
Core Cost of Sales, non-GAAP measure (a) | $ | 3,188 | $ | 3,854 | $ | 512 | $ | 3,528 | $ | 1,574 | $ | 945 | $ | — | $ | 13,601 | |||||||||||||||||||||||||||||||||||||
| Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Gross Profit, GAAP measure | $ | 5,002 | $ | 4,337 | $ | 1,067 | $ | 2,555 | $ | 2,108 | $ | 545 | $ | 6 | $ | 15,620 | 53.2 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (6) | (6) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 119 | — | — | (4) | 2 | — | — | 117 | 0.4 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 4 | 7 | — | — | — | — | — | 11 | — | ||||||||||||||||||||||||||||||||||||||||||||
Core Gross Profit, non-GAAP measure (a) | $ | 5,125 | $ | 4,344 | $ | 1,067 | $ | 2,551 | $ | 2,110 | $ | 545 | $ | — | $ | 15,742 | 53.6 | % | |||||||||||||||||||||||||||||||||||
| Reported Selling, General and Administrative Expenses, GAAP measure | $ | 3,292 | $ | 3,798 | $ | 546 | $ | 1,759 | $ | 1,399 | $ | 497 | $ | 772 | $ | 12,063 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (13) | (13) | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (78) | (89) | (7) | (81) | (14) | (3) | (21) | (293) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (1) | (130) | — | — | — | (3) | — | (134) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges/credits | — | 14 | — | — | — | — | — | 14 | |||||||||||||||||||||||||||||||||||||||||||||
| Pension and retiree medical-related impact | — | 30 | — | — | — | — | — | 30 | |||||||||||||||||||||||||||||||||||||||||||||
Core Selling, General and Administrative Expenses, non-GAAP measure (a) | $ | 3,213 | $ | 3,623 | $ | 539 | $ | 1,678 | $ | 1,385 | $ | 491 | $ | 738 | $ | 11,667 | |||||||||||||||||||||||||||||||||||||
| Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Operating Profit, GAAP measure | $ | 1,710 | $ | 539 | $ | 521 | $ | 796 | $ | 709 | $ | 48 | $ | (766) | $ | 3,557 | 12.1 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 7 | 7 | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 197 | 89 | 7 | 77 | 16 | 3 | 21 | 410 | 1.4 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 5 | 137 | — | — | — | 3 | — | 145 | 0.5 | ||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges/credits | — | (14) | — | — | — | — | — | (14) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Pension and retiree medical-related impact | — | (30) | — | — | — | — | — | (30) | (0.1) | ||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit, non-GAAP measure (a) | 1,912 | 721 | 528 | 873 | 725 | 54 | (738) | 4,075 | 13.9 | % | |||||||||||||||||||||||||||||||||||||||||||
Impact of foreign exchange translation (b) | 1 | — | (11) | (88) | (53) | 1 | — | (150) | |||||||||||||||||||||||||||||||||||||||||||||
Core Constant Currency Operating Profit, non-GAAP measure (a) | $ | 1,913 | $ | 721 | $ | 517 | $ | 785 | $ | 672 | $ | 55 | $ | (738) | $ | 3,925 | |||||||||||||||||||||||||||||||||||||
| Reported Operating Profit % Change, GAAP measure | (6) | n/m | 116 | 72 | 15 | n/m | 3 | 58 | |||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit % Change, non-GAAP measure (a) | (2) | 33 | 12 | 37 | 14 | n/m | (2) | 18 | |||||||||||||||||||||||||||||||||||||||||||||
Core Constant Currency Operating Profit % Change, non-GAAP measure (a) | (2) | 33 | 9 | 23 | 6 | n/m | (2) | 13 | |||||||||||||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate Unallocated Expenses | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Reported Cost of Sales, GAAP measure | $ | 3,224 | $ | 3,753 | $ | 697 | $ | 3,188 | $ | 1,418 | $ | 914 | $ | (13) | $ | 13,181 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 13 | 13 | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (68) | (45) | — | (4) | — | — | — | (117) | |||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | (218) | — | — | — | — | (218) | |||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | (2) | — | — | — | — | — | — | (2) | |||||||||||||||||||||||||||||||||||||||||||||
Core Cost of Sales, non-GAAP measure (a) | $ | 3,154 | $ | 3,708 | $ | 479 | $ | 3,184 | $ | 1,418 | $ | 914 | $ | — | $ | 12,857 | |||||||||||||||||||||||||||||||||||||
| Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Gross Profit, GAAP measure | $ | 4,967 | $ | 4,156 | $ | 827 | $ | 2,242 | $ | 1,896 | $ | 502 | $ | 13 | $ | 14,603 | 52.6 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (13) | (13) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 68 | 45 | — | 4 | — | — | — | 117 | 0.4 | ||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | 218 | — | — | — | — | 218 | 0.8 | ||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | 2 | — | — | — | — | — | — | 2 | — | ||||||||||||||||||||||||||||||||||||||||||||
Core Gross Profit, non-GAAP measure (a) | $ | 5,037 | $ | 4,201 | $ | 1,045 | $ | 2,246 | $ | 1,896 | $ | 502 | $ | — | $ | 14,927 | 53.7 | % | |||||||||||||||||||||||||||||||||||
| Reported Selling, General and Administrative Expenses, GAAP measure | $ | 3,141 | $ | 4,265 | $ | 586 | $ | 1,780 | $ | 1,280 | $ | 532 | $ | 760 | $ | 12,344 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 20 | 20 | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (46) | (50) | (9) | (37) | (17) | (3) | (26) | (188) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (9) | (1) | — | — | — | (5) | — | (15) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges | — | (556) | (4) | (135) | — | — | — | (695) | |||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | (1) | — | — | — | — | — | — | (1) | |||||||||||||||||||||||||||||||||||||||||||||
Core Selling, General and Administrative Expenses, non-GAAP measure (a) | $ | 3,085 | $ | 3,658 | $ | 573 | $ | 1,608 | $ | 1,263 | $ | 524 | $ | 754 | $ | 11,465 | |||||||||||||||||||||||||||||||||||||
| Reported Impairment of Intangible Assets, GAAP measure | $ | 9 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 9 | |||||||||||||||||||||||||||||||||||||
| Impairment and other charges | (9) | — | — | — | — | — | — | (9) | |||||||||||||||||||||||||||||||||||||||||||||
Core Impairment of Intangible Assets, non-GAAP measure (a) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||
| Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Operating Profit, GAAP measure | $ | 1,817 | $ | (109) | $ | 241 | $ | 462 | $ | 616 | $ | (30) | $ | (747) | $ | 2,250 | 8.1 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (33) | (33) | (0.1) | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 114 | 95 | 9 | 41 | 17 | 3 | 26 | 305 | 1.1 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 9 | 1 | — | — | — | 5 | — | 15 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges | 9 | 556 | 4 | 135 | — | — | — | 704 | 2.5 | ||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | 218 | — | — | — | — | 218 | 0.8 | ||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | 3 | — | — | — | — | — | — | 3 | — | ||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit, non-GAAP measure (a) | $ | 1,952 | $ | 543 | $ | 472 | $ | 638 | $ | 633 | $ | (22) | $ | (754) | $ | 3,462 | 12.5 | % | |||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate Unallocated Expenses | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Reported Cost of Sales, GAAP measure | $ | 10,789 | $ | 12,969 | $ | 1,529 | $ | 10,444 | $ | 4,482 | $ | 2,850 | $ | 3 | $ | 43,066 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (3) | (3) | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (221) | (6) | — | (7) | (2) | — | — | (236) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (4) | (53) | — | — | — | — | — | (57) | |||||||||||||||||||||||||||||||||||||||||||||
Core Cost of Sales, non-GAAP measure (a) | $ | 10,564 | $ | 12,910 | $ | 1,529 | $ | 10,437 | $ | 4,480 | $ | 2,850 | $ | — | $ | 42,770 | |||||||||||||||||||||||||||||||||||||
| Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Gross Profit, GAAP measure | $ | 16,739 | $ | 15,228 | $ | 3,468 | $ | 7,581 | $ | 6,067 | $ | 1,779 | $ | (3) | $ | 50,859 | 54.1 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 3 | 3 | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 221 | 6 | — | 7 | 2 | — | — | 236 | 0.3 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 4 | 53 | — | — | — | — | — | 57 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||
Core Gross Profit, non-GAAP measure (a) | $ | 16,964 | $ | 15,287 | $ | 3,468 | $ | 7,588 | $ | 6,069 | $ | 1,779 | $ | — | $ | 51,155 | 54.5 | % | |||||||||||||||||||||||||||||||||||
| Reported Selling, General and Administrative Expenses, GAAP measure | $ | 10,566 | $ | 12,550 | $ | 1,626 | $ | 5,224 | $ | 4,057 | $ | 1,330 | $ | 2,015 | $ | 37,368 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 4 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (123) | (275) | (14) | (188) | (50) | (12) | (66) | (728) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (24) | (319) | — | — | — | (3) | — | (346) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges/credits | — | 16 | — | (19) | — | — | — | (3) | |||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | — | — | (82) | — | — | (82) | |||||||||||||||||||||||||||||||||||||||||||||
| Pension and retiree medical-related impact | — | 30 | — | — | — | — | — | 30 | |||||||||||||||||||||||||||||||||||||||||||||
Core Selling, General and Administrative Expenses, non-GAAP measure (a) | $ | 10,419 | $ | 12,002 | $ | 1,612 | $ | 5,017 | $ | 3,925 | $ | 1,315 | $ | 1,953 | $ | 36,243 | |||||||||||||||||||||||||||||||||||||
| Reported Impairment of Intangible Assets, GAAP measure | $ | — | $ | 1,589 | $ | 73 | $ | 251 | $ | — | $ | 80 | $ | — | $ | 1,993 | |||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | — | (50) | — | — | — | — | — | (50) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges/credits | — | (1,539) | (73) | (251) | — | (80) | — | (1,943) | |||||||||||||||||||||||||||||||||||||||||||||
Core Impairment of Intangible Assets, non-GAAP measure (a) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||
| Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Operating Profit, GAAP measure | $ | 6,173 | $ | 1,089 | $ | 1,769 | $ | 2,106 | $ | 2,010 | $ | 369 | $ | (2,018) | $ | 11,498 | 12.2 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (1) | (1) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 344 | 281 | 14 | 195 | 52 | 12 | 66 | 964 | 1.0 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 28 | 422 | — | — | — | 3 | — | 453 | 0.5 | ||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges/credits | — | 1,523 | 73 | 270 | — | 80 | — | 1,946 | 2.1 | ||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | — | — | 82 | — | — | 82 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||
| Pension and retiree medical-related impact | — | (30) | — | — | — | — | — | (30) | — | ||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit, non-GAAP measure (a) | 6,545 | 3,285 | 1,856 | 2,571 | 2,144 | 464 | (1,953) | 14,912 | 15.9 | % | |||||||||||||||||||||||||||||||||||||||||||
Impact of foreign exchange translation (b) | 7 | 4 | 9 | (104) | 117 | 3 | — | 36 | |||||||||||||||||||||||||||||||||||||||||||||
Core Constant Currency Operating Profit, non-GAAP measure (a) | $ | 6,552 | $ | 3,289 | $ | 1,865 | $ | 2,467 | $ | 2,261 | $ | 467 | $ | (1,953) | $ | 14,948 | |||||||||||||||||||||||||||||||||||||
| Reported Operating Profit % Change, GAAP measure | (7) | (53) | 21 | 7 | (2) | (2) | 6 | (11) | |||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit % Change, non-GAAP measure (a) | (6) | 6 | 9 | 15 | 2 | 19 | 7 | 1.5 | |||||||||||||||||||||||||||||||||||||||||||||
Core Constant Currency Operating Profit % Change, non-GAAP measure (a) | (6) | 6 | 9 | 10 | 8 | 20 | 7 | 2 | |||||||||||||||||||||||||||||||||||||||||||||
| PFNA | PBNA | IB Franchise | EMEA | LatAm Foods | Asia Pacific Foods | Corporate Unallocated Expenses | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Reported Cost of Sales, GAAP measure | $ | 10,495 | $ | 12,749 | $ | 1,700 | $ | 9,646 | $ | 4,423 | $ | 2,757 | $ | (26) | $ | 41,744 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | 26 | 26 | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (74) | (48) | — | (7) | (3) | (1) | — | (133) | |||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | (218) | — | — | — | — | (218) | |||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | (176) | — | — | — | — | — | — | (176) | |||||||||||||||||||||||||||||||||||||||||||||
Core Cost of Sales, non-GAAP measure (a) | $ | 10,245 | $ | 12,701 | $ | 1,482 | $ | 9,639 | $ | 4,420 | $ | 2,756 | $ | — | $ | 41,243 | |||||||||||||||||||||||||||||||||||||
| Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Gross Profit, GAAP measure | $ | 16,936 | $ | 15,020 | $ | 3,179 | $ | 7,012 | $ | 6,145 | $ | 1,792 | $ | 26 | $ | 50,110 | 54.6 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (26) | (26) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 74 | 48 | — | 7 | 3 | 1 | — | 133 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | 218 | — | — | — | — | 218 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | 176 | — | — | — | — | — | — | 176 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||||
Core Gross Profit, non-GAAP measure (a) | $ | 17,186 | $ | 15,068 | $ | 3,397 | $ | 7,019 | $ | 6,148 | $ | 1,793 | $ | — | $ | 50,611 | 55.1 | % | |||||||||||||||||||||||||||||||||||
| Reported Selling, General and Administrative Expenses, GAAP measure | $ | 10,308 | $ | 12,718 | $ | 1,703 | $ | 5,031 | $ | 4,093 | $ | 1,415 | $ | 1,922 | $ | 37,190 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (1) | (1) | |||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | (87) | (190) | (10) | (109) | (46) | (8) | (101) | (551) | |||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | (9) | (8) | — | — | — | (5) | — | (22) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges | — | (556) | (4) | (135) | — | — | — | (695) | |||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | (8) | — | — | — | — | — | — | (8) | |||||||||||||||||||||||||||||||||||||||||||||
Core Selling, General and Administrative Expenses, non-GAAP measure (a) | $ | 10,204 | $ | 11,964 | $ | 1,689 | $ | 4,787 | $ | 4,047 | $ | 1,402 | $ | 1,820 | $ | 35,913 | |||||||||||||||||||||||||||||||||||||
| Reported Impairment of Intangible Assets, GAAP measure | $ | 9 | $ | — | $ | 14 | $ | 10 | $ | — | $ | — | $ | — | $ | 33 | |||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | — | — | (14) | — | — | — | — | (14) | |||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges | (9) | — | — | (10) | — | — | — | (19) | |||||||||||||||||||||||||||||||||||||||||||||
Core Impairment of Intangible Assets, non-GAAP measure (a) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||||||||||||
| Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported Operating Profit, GAAP measure | $ | 6,619 | $ | 2,302 | $ | 1,462 | $ | 1,971 | $ | 2,052 | $ | 377 | $ | (1,896) | $ | 12,887 | 14.0 | % | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | — | — | — | — | (25) | (25) | — | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and impairment charges | 161 | 238 | 24 | 116 | 49 | 9 | 101 | 698 | 0.8 | ||||||||||||||||||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | 9 | 8 | — | — | — | 5 | — | 22 | — | ||||||||||||||||||||||||||||||||||||||||||||
| Impairment and other charges | 9 | 556 | 4 | 145 | — | — | — | 714 | 0.8 | ||||||||||||||||||||||||||||||||||||||||||||
| Indirect tax impact | — | — | 218 | — | — | — | — | 218 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||||
| Product recall-related impact | 184 | — | — | — | — | — | — | 184 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||||
Core Operating Profit, non-GAAP measure (a) | $ | 6,982 | $ | 3,104 | $ | 1,708 | $ | 2,232 | $ | 2,101 | $ | 391 | $ | (1,820) | $ | 14,698 | 16.0 | % | |||||||||||||||||||||||||||||||||||
| Quarter Ended 12/27/2025 | |||||||||||||||||||||||||||||
| Other pension and retiree medical benefits (expense)/income | Provision for income taxes(a) | Net income attributable to PepsiCo | Net income attributable to PepsiCo per common share - diluted | Effective tax rate(b) | |||||||||||||||||||||||||
| Reported, GAAP measure | $ | (224) | $ | 445 | $ | 2,540 | $ | 1.85 | 14.8 | % | |||||||||||||||||||
| Items Affecting Comparability | |||||||||||||||||||||||||||||
| Mark-to-market net impact | — | 2 | 5 | — | — | ||||||||||||||||||||||||
| Restructuring and impairment charges | 6 | 91 | 325 | 0.24 | 0.5 | ||||||||||||||||||||||||
Acquisition and divestiture-related charges | — | 34 | 111 | 0.08 | 0.3 | ||||||||||||||||||||||||
Impairment and other charges/credits (c) | — | 34 | (48) | (0.04) | 1.2 | ||||||||||||||||||||||||
Indirect and income tax impact (d) | — | 18 | (18) | (0.01) | 0.6 | ||||||||||||||||||||||||
| Pension and retiree medical-related impact | 267 | 51 | 186 | 0.14 | 0.3 | ||||||||||||||||||||||||
Core, non-GAAP measure (e) | $ | 49 | $ | 675 | $ | 3,101 | $ | 2.26 | 17.8 | % | |||||||||||||||||||
| Quarter Ended 12/28/2024 | |||||||||||||||||||||||||||||||||||
| Other pension and retiree medical benefits (expense)/income | (Benefit from)/Provision for income taxes(a) | Net income attributable to noncontrolling interests | Net income attributable to PepsiCo | Net income attributable to PepsiCo per common share - diluted | Effective tax rate(b) | ||||||||||||||||||||||||||||||
| Reported, GAAP measure | $ | (177) | $ | 275 | $ | 11 | $ | 1,523 | $ | 1.11 | 15.2 | % | |||||||||||||||||||||||
| Items Affecting Comparability | |||||||||||||||||||||||||||||||||||
| Mark-to-market net impact | — | (8) | — | (25) | (0.02) | (0.1) | |||||||||||||||||||||||||||||
| Restructuring and impairment charges | 7 | 74 | (1) | 239 | 0.17 | 1.0 | |||||||||||||||||||||||||||||
| Acquisition and divestiture-related charges | — | 2 | — | 13 | 0.01 | — | |||||||||||||||||||||||||||||
| Impairment and other charges | — | 182 | — | 522 | 0.38 | 3.2 | |||||||||||||||||||||||||||||
| Indirect and income tax impact | — | — | — | 218 | 0.16 | (2.1) | |||||||||||||||||||||||||||||
| Product recall-related impact | — | 1 | — | 2 | — | — | |||||||||||||||||||||||||||||
| Pension and retiree medical-related impact | 259 | 58 | — | 201 | 0.15 | 0.7 | |||||||||||||||||||||||||||||
Core, non-GAAP measure (e) | $ | 89 | $ | 584 | $ | 10 | $ | 2,693 | $ | 1.96 | 17.8 | % | |||||||||||||||||||||||
| Year Ended 12/27/2025 | |||||||||||||||||||||||||||||
| Other pension and retiree medical benefits (expense)/income | Provision for income taxes(a) | Net income attributable to PepsiCo | Net income attributable to PepsiCo per common share - diluted | Effective tax rate(b) | |||||||||||||||||||||||||
| Reported, GAAP measure | $ | (133) | $ | 1,949 | $ | 8,240 | $ | 6.00 | 19.0 | % | |||||||||||||||||||
| Items Affecting Comparability | |||||||||||||||||||||||||||||
| Mark-to-market net impact | — | — | (1) | — | — | ||||||||||||||||||||||||
| Restructuring and impairment charges | 19 | 191 | 792 | 0.58 | — | ||||||||||||||||||||||||
| Acquisition and divestiture-related charges | — | 106 | 347 | 0.25 | 0.2 | ||||||||||||||||||||||||
| Impairment and other charges | — | 455 | 1,491 | 1.09 | 0.7 | ||||||||||||||||||||||||
Indirect and income tax impact (c) | — | (29) | 111 | 0.08 | (0.4) | ||||||||||||||||||||||||
| Pension and retiree medical-related impact | 279 | 53 | 196 | 0.14 | 0.1 | ||||||||||||||||||||||||
Core, non-GAAP measure (d) | $ | 165 | $ | 2,725 | $ | 11,176 | $ | 8.14 | 19.5 | % | |||||||||||||||||||
| Year Ended 12/28/2024 | |||||||||||||||||||||||||||||
| Other pension and retiree medical benefits (expense)/income | (Benefit from)/Provision for income taxes(a) | Net income attributable to PepsiCo | Net income attributable to PepsiCo per common share - diluted | Effective tax rate(b) | |||||||||||||||||||||||||
| Reported, GAAP measure | $ | (22) | $ | 2,320 | $ | 9,578 | $ | 6.95 | 19.4 | % | |||||||||||||||||||
| Items Affecting Comparability | |||||||||||||||||||||||||||||
| Mark-to-market net impact | — | (6) | (19) | (0.01) | — | ||||||||||||||||||||||||
| Restructuring and impairment charges | 29 | 164 | 563 | 0.41 | 0.2 | ||||||||||||||||||||||||
| Acquisition and divestiture-related charges | — | 4 | 18 | 0.01 | — | ||||||||||||||||||||||||
| Impairment and other charges | — | 184 | 530 | 0.38 | 0.4 | ||||||||||||||||||||||||
| Indirect and income tax impact | — | — | 218 | 0.16 | (0.4) | ||||||||||||||||||||||||
| Product recall-related impact | 3 | 44 | 143 | 0.10 | 0.1 | ||||||||||||||||||||||||
| Pension and retiree medical-related impact | 276 | 61 | 215 | 0.16 | 0.1 | ||||||||||||||||||||||||
Core, non-GAAP measure (d) | $ | 286 | $ | 2,771 | $ | 11,246 | $ | 8.16 | 19.7 | % | |||||||||||||||||||
{
"version": "2.2",
"instance": {
"pep-20260203.htm": {
"nsprefix": "pep",
"nsuri": "http://www.pepsico.com/20260203",
"dts": {
"inline": {
"local": [
"pep-20260203.htm"
]
},
"schema": {
"local": [
"pep-20260203.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
"https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
"https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
"https://xbrl.sec.gov/country/2025/country-2025.xsd",
"https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
"https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
]
},
"definitionLink": {
"local": [
"pep-20260203_def.xml"
]
},
"labelLink": {
"local": [
"pep-20260203_lab.xml"
]
},
"presentationLink": {
"local": [
"pep-20260203_pre.xml"
]
}
},
"keyStandard": 22,
"keyCustom": 0,
"axisStandard": 1,
"axisCustom": 0,
"memberStandard": 1,
"memberCustom": 13,
"hidden": {
"total": 2,
"http://xbrl.sec.gov/dei/2025": 2
},
"contextCount": 15,
"entityCount": 1,
"segmentCount": 14,
"elementCount": 41,
"unitCount": 0,
"baseTaxonomies": {
"http://xbrl.sec.gov/dei/2025": 61
},
"report": {
"R1": {
"role": "http://www.pepsico.com/role/DocumentandEntityInformation",
"longName": "0000001 - Document - Document and Entity Information",
"shortName": "Document and Entity Information",
"isDefault": "true",
"groupType": "document",
"subGroupType": "",
"menuCat": "Cover",
"order": "1",
"firstAnchor": {
"contextRef": "c-1",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "pep-20260203.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "c-1",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"div",
"body",
"html"
],
"reportCount": 1,
"baseRef": "pep-20260203.htm",
"first": true,
"unique": true
}
}
},
"tag": {
"dei_AmendmentFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "AmendmentFlag",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Amendment Flag",
"label": "Amendment Flag",
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
}
}
},
"auth_ref": []
},
"dei_CityAreaCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CityAreaCode",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "City Area Code",
"label": "City Area Code",
"documentation": "Area code of city"
}
}
},
"auth_ref": []
},
"us-gaap_ClassOfStockDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "ClassOfStockDomain",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Class of Stock [Domain]",
"label": "Class of Stock [Domain]"
}
}
},
"auth_ref": []
},
"us-gaap_CommonStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "CommonStockMember",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Common Stock, par value 1-2/3 cents per share",
"label": "Common Stock [Member]"
}
}
},
"auth_ref": []
},
"dei_CoverAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "CoverAbstract",
"lang": {
"en-us": {
"role": {
"terseLabel": "Cover [Abstract]",
"label": "Cover [Abstract]",
"documentation": "Cover page."
}
}
},
"auth_ref": []
},
"dei_DocumentPeriodEndDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentPeriodEndDate",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Document Period End Date",
"label": "Document Period End Date",
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
}
}
},
"auth_ref": []
},
"dei_DocumentType": {
"xbrltype": "submissionTypeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "DocumentType",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Document Type",
"label": "Document Type",
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine1": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressAddressLine1",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Address, Address Line One",
"label": "Entity Address, Address Line One",
"documentation": "Address Line 1 such as Attn, Building Name, Street Name"
}
}
},
"auth_ref": []
},
"dei_EntityAddressCityOrTown": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressCityOrTown",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Address, City or Town",
"label": "Entity Address, City or Town",
"documentation": "Name of the City or Town"
}
}
},
"auth_ref": []
},
"dei_EntityAddressPostalZipCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressPostalZipCode",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Address, Postal Zip Code",
"label": "Entity Address, Postal Zip Code",
"documentation": "Code for the postal or zip code"
}
}
},
"auth_ref": []
},
"dei_EntityAddressStateOrProvince": {
"xbrltype": "stateOrProvinceItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityAddressStateOrProvince",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Address, State or Province",
"label": "Entity Address, State or Province",
"documentation": "Name of the state or province."
}
}
},
"auth_ref": []
},
"dei_EntityCentralIndexKey": {
"xbrltype": "centralIndexKeyItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityCentralIndexKey",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Central Index Key",
"label": "Entity Central Index Key",
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
}
}
},
"auth_ref": [
"r1"
]
},
"dei_EntityEmergingGrowthCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityEmergingGrowthCompany",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Emerging Growth Company",
"label": "Entity Emerging Growth Company",
"documentation": "Indicate if registrant meets the emerging growth company criteria."
}
}
},
"auth_ref": [
"r1"
]
},
"dei_EntityFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityFileNumber",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity File Number",
"label": "Entity File Number",
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
}
}
},
"auth_ref": []
},
"dei_EntityIncorporationStateCountryCode": {
"xbrltype": "edgarStateCountryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityIncorporationStateCountryCode",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Incorporation, State or Country Code",
"label": "Entity Incorporation, State or Country Code",
"documentation": "Two-character EDGAR code representing the state or country of incorporation."
}
}
},
"auth_ref": []
},
"dei_EntityListingsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingsLineItems",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Document and Entity Information [Line Items]",
"label": "Entity Listings [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityListingsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityListingsTable",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Listings [Table]",
"label": "Entity Listings [Table]",
"documentation": "Container for exchange listing information for an entity"
}
}
},
"auth_ref": []
},
"dei_EntityRegistrantName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityRegistrantName",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Registrant Name",
"label": "Entity Registrant Name",
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
}
}
},
"auth_ref": [
"r1"
]
},
"dei_EntityTaxIdentificationNumber": {
"xbrltype": "employerIdItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "EntityTaxIdentificationNumber",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Entity Tax Identification Number",
"label": "Entity Tax Identification Number",
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
}
}
},
"auth_ref": [
"r1"
]
},
"pep_FourPointZeroFivePercentNotesDue2055Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "FourPointZeroFivePercentNotesDue2055Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "4.050% Senior Notes Due 2055",
"label": "Four Point Zero Five Percent Notes Due 2055 [Member]",
"documentation": "Four Point Zero Five Percent Notes Due 2055"
}
}
},
"auth_ref": []
},
"dei_LocalPhoneNumber": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "LocalPhoneNumber",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Local Phone Number",
"label": "Local Phone Number",
"documentation": "Local phone number for entity."
}
}
},
"auth_ref": []
},
"pep_OnePointOneTwoFivePercentNotesDue2031Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "OnePointOneTwoFivePercentNotesDue2031Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "1.125% Senior Notes Due 2031",
"label": "One Point One Two Five Percent Notes Due 2031 [Member]",
"documentation": "One Point One Two Five Percent Notes Due 2031 [Member]"
}
}
},
"auth_ref": []
},
"pep_OnePointZeroFivePercentNotesDue2050Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "OnePointZeroFivePercentNotesDue2050Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "1.050% Senior Notes Due 2050",
"label": "One Point Zero Five Percent Notes Due 2050 [Member]",
"documentation": "One Point Zero Five Percent Notes Due 2050"
}
}
},
"auth_ref": []
},
"dei_PreCommencementIssuerTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreCommencementIssuerTenderOffer",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Pre-commencement Issuer Tender Offer",
"label": "Pre-commencement Issuer Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
}
}
},
"auth_ref": [
"r3"
]
},
"dei_PreCommencementTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "PreCommencementTenderOffer",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Pre-commencement Tender Offer",
"label": "Pre-commencement Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
}
}
},
"auth_ref": [
"r5"
]
},
"dei_Security12bTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "Security12bTitle",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Title of 12(b) Security",
"label": "Title of 12(b) Security",
"documentation": "Title of a 12(b) registered security."
}
}
},
"auth_ref": [
"r0"
]
},
"dei_SecurityExchangeName": {
"xbrltype": "edgarExchangeCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "SecurityExchangeName",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Security Exchange Name",
"label": "Security Exchange Name",
"documentation": "Name of the Exchange on which a security is registered."
}
}
},
"auth_ref": [
"r2"
]
},
"dei_SolicitingMaterial": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "SolicitingMaterial",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Soliciting Material",
"label": "Soliciting Material",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
}
}
},
"auth_ref": [
"r4"
]
},
"us-gaap_StatementClassOfStockAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2025",
"localname": "StatementClassOfStockAxis",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Class of Stock [Axis]",
"label": "Class of Stock [Axis]"
}
}
},
"auth_ref": []
},
"pep_ThreePointFiveFivePercentNotesDue2034Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ThreePointFiveFivePercentNotesDue2034Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "3.550% Senior Notes Due 2034",
"label": "Three Point Five Five Percent Notes Due 2034 [Member]",
"documentation": "Three Point Five Five Percent Notes Due 2034"
}
}
},
"auth_ref": []
},
"pep_ThreePointFourFivePercentNotesDue2037Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ThreePointFourFivePercentNotesDue2037Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "3.450% Senior Notes Due 2037",
"label": "Three Point Four Five Percent Notes Due 2037 [Member]",
"documentation": "Three Point Four Five Percent Notes Due 2037"
}
}
},
"auth_ref": []
},
"pep_ThreePointTwoPercentNotesDue2029Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ThreePointTwoPercentNotesDue2029Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "3.200% Senior Notes Due 2029",
"label": "Three Point Two Percent Notes Due 2029 [Member]",
"documentation": "Three Point Two Percent Notes Due 2029"
}
}
},
"auth_ref": []
},
"dei_TradingSymbol": {
"xbrltype": "tradingSymbolItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "TradingSymbol",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Trading Symbol",
"label": "Trading Symbol",
"documentation": "Trading symbol of an instrument as listed on an exchange."
}
}
},
"auth_ref": []
},
"pep_TwoPointSixTwoFivePercentNotesDue2026Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "TwoPointSixTwoFivePercentNotesDue2026Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "2.625% Senior Notes Due 2026",
"label": "Two Point Six Two Five Percent Notes Due 2026 [Member]",
"documentation": "Two Point Six Two Five Percent Notes Due 2026 [Member]"
}
}
},
"auth_ref": []
},
"dei_WrittenCommunications": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2025",
"localname": "WrittenCommunications",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "Written Communications",
"label": "Written Communications",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
}
}
},
"auth_ref": [
"r6"
]
},
"pep_ZeroPointEightSevenFiveNotesDue2039Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointEightSevenFiveNotesDue2039Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.875% Senior Notes Due 2039",
"label": "Zero Point Eight Seven Five Notes Due 2039 [Member]",
"documentation": "Zero Point Eight Seven Five Notes Due 2039 [Member]"
}
}
},
"auth_ref": []
},
"pep_ZeroPointEightSevenFivePercentNotesDue2028Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointEightSevenFivePercentNotesDue2028Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.875% Senior Notes Due 2028",
"label": "Zero Point Eight Seven Five Percent Notes Due 2028 [Member]",
"documentation": "Zero Point Eight Seven Five Percent Notes Due 2028 [Member]"
}
}
},
"auth_ref": []
},
"pep_ZeroPointFivePercentNotesDue2028Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointFivePercentNotesDue2028Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.500% Senior Notes Due 2028",
"label": "Zero Point Five Percent Notes Due 2028 [Member]",
"documentation": "Zero Point Five Percent Notes Due 2028"
}
}
},
"auth_ref": []
},
"pep_ZeroPointFourPercentNotesDue2032Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointFourPercentNotesDue2032Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.400% Senior Notes Due 2032",
"label": "Zero Point Four Percent Notes Due 2032 [Member]",
"documentation": "Zero Point Four Percent Notes Due 2032"
}
}
},
"auth_ref": []
},
"pep_ZeroPointSevenFivePercentNotesDue2027Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointSevenFivePercentNotesDue2027Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.750% Senior Notes Due 2027",
"label": "Zero Point Seven Five Percent Notes Due 2027 [Member]",
"documentation": "Zero Point Seven Five Percent Notes Due 2027 [Member]"
}
}
},
"auth_ref": []
},
"pep_ZeroPointSevenFivePercentNotesDue2033Member": {
"xbrltype": "domainItemType",
"nsuri": "http://www.pepsico.com/20260203",
"localname": "ZeroPointSevenFivePercentNotesDue2033Member",
"presentation": [
"http://www.pepsico.com/role/DocumentandEntityInformation"
],
"lang": {
"en-us": {
"role": {
"terseLabel": "0.750% Senior Notes Due 2033",
"label": "Zero Point Seven Five Percent Notes Due 2033 [Member]",
"documentation": "Zero Point Seven Five Percent Notes Due 2033 [Member]"
}
}
},
"auth_ref": []
}
}
}
},
"std_ref": {
"r0": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b"
},
"r1": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-2"
},
"r2": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "d1-1"
},
"r3": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "13e",
"Subsection": "4c"
},
"r4": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14a",
"Subsection": "12"
},
"r5": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14d",
"Subsection": "2b"
},
"r6": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "425"
}
}
}